您要查找的是不是：
- Bisoprolol Hemifumarate 比索洛尔富马酸盐, 康可, 富马酸比索洛尔
- Objective:To optimize the synthesis of antipsychotic drug quetiapine hemifumarate. 目的:改进抗精神病药半富马酸喹硫平的合成工艺。
- The occurrence rate of adverse reaction was 35% for the Bisoprolol group and 60% for the Carvedilol group,indicating a statistical difference(P<0.01). 不良反应发生率比索洛尔组为35%25;卡维地洛组为60%25;有统计学差异(P<0.;01);
- Objective: To prepare bisoprolol fumarate tablets and to assay the content uniformity and dissolution of tablets. 摘要目的：制备富马酸比索洛尔片，并测定其含量均匀度和溶出度。
- When heart failure was developed, the operated rats were randomly administrated placebo and bisoprolol (0.8mg/Kg). 随机分别给予安慰剂或比索洛尔（0.;8mg/kg，1次/日）灌胃。
- Long-term administration of bisoprolol in chronic, stable heart failure may improve left ventricular function. 比索洛尔长期用于慢性、稳定型心力衰竭病人，可使心力衰竭病人左室功能改善。
- To study the clinical efficacy of Bisoprolol in the treatmant of chronic heart falure. 摘要目的探讨比索洛尔治疗慢性心力衰竭的临床疗效。
- To evaluate effects of selective Bisoprolol on baroreceptor in patients withheart failure secondary to dilated cardiomyopathy (DCM). 探讨比索洛尔治疗心力衰竭时对对压力感受器功能的影响。
- Bisoprolol and lacidipine had greater reduction of 24h mean and daytime mean ambulatory blood pressures than that of lisinopril. 比索洛尔和拉西地平降低24小时平均和白天平均血压的幅度大于赖诺普利。
- The target dosages were metoprolol 100 mg bid in 30 cases,bisoprolol 10 mg qd in 23 cases,and carvedilol 25 mg bid in 22 cases. 23例应用比索洛尔,靶剂量10mg,1次/d; 22例应用卡维地洛,靶剂量为25mg,2次/d。
- Objective?To compare the antihypertensive effects of bisoprolol, lacidipine and losinopril in 29 patients with essential hypertension.Methods? 目的?比较比索洛尔、拉西地平和赖诺普利对29例高血压病患者的降压疗效。
- To compare the antihypertensive effects of bisoprolol, lacidipine and losinopril in 29 patients with essential hypertension. 比较比索洛尔、拉西地平和赖诺普利对29例高血压病患者的降压疗效。
- Conclusion:Bisoprolol is effective on the recovery of baroreceptive abnormalities in patients withheart failure secondary to DCM. 结论：比索洛尔对DCM心力衰竭患者的压力感受器功能有明显恢复作用。
- The good tolerance to Bisoprolol was found in CHF patients with different cardiac rhythm and was better in patients with AF and cardiac pacing rhythm than with sinus one. 不同心律的CHF患者对比索洛尔的耐受性均较好,且房颤和起博器心律者好于窦律患者。
- Objective To research the characteristics of heart rate variability(HRV) of patients with unstable angina pectoris(UAP) and effects of bisoprolol for HRV. 目的探讨心率变异性(HRV)在不稳定型心绞痛(UAP)发病中的变化及临床意义。
- The rapid rise in blood pressure in the morning hours was well controlled by all the three drugs, however, bisoprolol and lacidipine were better than lisinopril. 比索洛尔和拉西地平降低24小时平均和白天平均血压的幅度大于赖诺普利。
- These increases, with corresponding decreases in receptor actiation, were minor for metoprolol and bisoprolol, and the effects did not did not differ between receptor ariants. 上述比率的增加伴随相应的受体活性下降，在美托洛尔和比索洛尔的作用过程中是很小的，而且抑制效应并未因受体变异而发生改变。
- Clinical study showed that in treatment of heart failure, bisoprolol is able to decrease the total and cardiovascular mortality, together with re-admission rate. 临床研究表明比索洛尔用于心力衰竭病人，可降低总死亡率和心血管死亡率，减少再入院发生率。
- The changes of these substances were compared before and after treatment.46 EH patients were treated with lisinopril,20 with amlodipine and 18 with Bisoprolol. 46名患者用赖诺普利治疗，20名用氨氯地平治疗，18名用比索洛尔治疗，疗程均为8周。
- Methods Bisoprolol was orally administealed in CHF Patients [102 with sinus rhythm, 28 with atrial fibrillation (AF) rhythm and 12 with cardiac pacing rhythm] at the basis of regular regimen and the dosage was increasingly added to the target dose. 方法对142例CHF患者[其中窦性心律(窦律)102例,心房颤动(房颤)心律28例,起博器心律12例]在常规心力衰竭(心衰)治疗基础上口服比索洛尔,逐渐加量至目标剂量。
